Isle Of Man, Sept. 01, 2022 (GLOBE NEWSWIRE) -- Douglas Insights has further expanded its comparison engine with Hereditary Testing Market research reports, allowing market researchers, analysts, industry experts, and businesses to identify market trends, drivers of growth, limitations, obstacles, and predictions. Douglas Insights is the world's first comparison engine for market research reports. With access to the widest range of private and public market reports, the digital tool lets researchers compare various reports by Publisher Rating, Table of Contents, Date of Publication, and Price.
Market Report Scope-
| Report Metrics | Details |
| Market size available for years | 2022-2030 |
| Market Value in 2021 | USD XX billion |
| CAGR | 9.2% |
| Forecast units | USD Bn |
| Base Year | 2021 |
| Past data | 2016 – 2021 |
| Forecast period | 2030 |
| Regions covered | Germany, UK, France, Italy, Spain, Russia, U.S., Canada, Mexico, Brazil, Argentina, China, Japan, India, South Korea, Israel, GCC countries, South Africa, Turkey, etc. |
| Companies covered | Natera, Inc., Myriad Genetics, Inc., Quest Diagnostics Incorporated, Invitae Corporation, F.Hoffmann-La Roche Ltd., Illumina, Inc., MedGenome, CooperSurgical, Inc., Twist Bioscience, Fulgent Genetics, Inc., Sophia Genetics, Agilent Technologies, Inc., Laboratory Corporation of America Holdings, Thermo Fisher Scientific, Inc., and CENTOGENE N.V. |
The global hereditary testing market took a hit with the outbreak of the SARS-COV2 virus but is expected to expand significantly in the near future, with an estimated compound annual growth rate of 9.2% between 2022 and 2030. Reproductive genetic testing is identified as the key market driver. Within it, hereditary non-cancer testing remains the dominant segment. In terms of market players, Europe was the leading player in 2021 with the largest revenue share and is expected to maintain its position during the forecast period of 2022 to 2030. Europe's lead in the market is attributed to three key factors - the widespread adoption of advanced medical treatments, government agencies providing recommendations to ensure the quality of hereditary testing services, and the presence of major players that offer genetic testing services and kits.
Compare the reports on Hereditary Testing Market- https://douglasinsights.com/hereditary-testing-market
While Europe is predicted to retain its lead in the global hereditary market until 2030 (at least), North America will also experience a good boost in revenue with improvements in genetic testing for hereditary disorders. The region will also emerge as a key market player due to the rising demand for IVF, increasing adoption of pre-implantation testing, and an ever-increasing number of people wanting to identify their lineage. The use of genetic testing for cancer detection, increasing prevalence of infectious, autoimmune diseases, ongoing research and advancements that lead to the availability of new, better products and technology are the major factors driving the hereditary testing market in North America.
The increasing prevalence of hereditary disorders, the spread of cancer, and rising awareness about the role of gene mutation in disease occurrence are the key drivers of growth in the global genetic testing market. Advancements in hereditary testing techniques and technology are also expected to propel growth in the said market during the forecast period, and so do the gradually rising demand for hereditary testing in developing countries. The untapped markets and increasing healthcare investments in China, India, and Brazil will also offer several opportunities for major market players. However, stringent requirements for product approvals and concerns over the standardisation of hereditary testing-based diagnostic procedures are expected to pose challenges and may also affect the genetic testing market growth. The lack of skilled professionals in developing and underdeveloped countries and the high cost of hereditary testing are also expected to pose challenges to market expansion and growth by limiting the availability and rate of adoption.
For creating custom project Sign up here - https://douglasinsights.com/auth/register
Some of the key global players in the hereditary testing market include Natera, Inc., Myriad Genetics, Inc., Quest Diagnostics Incorporated, Invitae Corporation, F.Hoffmann-La Roche Ltd., Illumina, Inc., MedGenome, CooperSurgical, Inc., Twist Bioscience, Fulgent Genetics, Inc., Sophia Genetics, Agilent Technologies, Inc., Laboratory Corporation of America Holdings, Thermo Fisher Scientific, Inc., and CENTOGENE N.V.
In terms of hereditary testing services, the ones that make up the major market share include diagnostic testing, pre-symptomatic or predictive testing, prenatal testing, newborn testing, carrier testing, pharmacogenetics testing, and nutrigenomics. Diagnoses of cancer, cardiovascular diseases, and genetic diseases are the predominant applications for hereditary testing.
Key questions answered in this report
- COVID 19 impact analysis on global Hereditary Testing industry.
- What are the current market trends and dynamics in the Hereditary Testing market and valuable opportunities for emerging players?
- What is driving Hereditary Testing market?
- What are the key challenges to market growth?
- Which segment accounts for the fastest CAGR during the forecast period?
- Which product type segment holds a larger market share and why?
- Are low and middle-income economies investing in the Hereditary Testing market?
- Key growth pockets on the basis of regions, types, applications, and end-users
- What is the market trend and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
Unique data points of this report
- Statistics on Hereditary Testing and spending worldwide
- Recent trends across different regions in terms of adoption of Hereditary Testing across industries
- Notable developments going on in the industry
- Attractive investment proposition for segments as well as geography
- Comparative scenario for all the segments for years 2018 (actual) and 2031 (forecast)
Compare the reports on Hereditary Testing Market- https://douglasinsights.com/hereditary-testing-market
Related Market Research Report Comparisons:
Compare Hereditary Angioedema Market-The Hereditary Testing market is expected to grow significantly in the next few years. This is due to the increasing awareness of the importance of genetic testing and the advancement of technology that makes it easier and more affordable to conduct such tests. In addition, there is also a growing trend of people wanting to know more about their family history and health risks. With all of these factors, it is no wonder that the Hereditary Testing market is expected to boom in the near future.
Biologics Safety Testing Market- The Biologics Safety Testing Market is expected to face a general upward trend in the next forecast period, with a significant CAGR growth. There are a few major driving factors for the market’s growth: the growth of related biologics and biosimilar markets, the increase in investment and research and development in biopharmaceutical companies, and the increasing concerns about cell culture contamination.
About Douglas Insights-
Douglas Insights UK limited is the first company to provide comparison of market research reports by Table of content, price, ratings and number of pages. We understand the value of time. Productivity and efficiency are possible when you take prompt and assured decisions. With our advanced algorithm, filters, and comparison engine, you can compare your preferred reports simultaneously, based on publisher rating, published date, price, and list of tables. Our data portal enables you to find and review the reports from several publishers. You can evaluate numerous reports on the same screen and select the sample for your best match.
